Evidence map›Paper›PMID 21957198›Full record

ArticleJournal of lipid research2011

A biochemical fluorometric method for assessing the oxidative properties of HDL.

Theodoros Kelesidis, Judith S Currier, Diana Huynh, David Meriwether, Christina Charles-Schoeman, Srinivasa T Reddy, Alan M Fogelman, Mohamad Navab, Otto O Yang

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases.Therapeutic advances in musculoskeletal disease · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Theodoros KelesidisDepartment of Medicine, University of California, Los Angeles, CA 90095. Electronic address: tkelesidis@mednet.ucla.edu.
Judith S CurrierDepartment of Medicine, University of California, Los Angeles, CA 90095.
Diana HuynhDepartment of Medicine, University of California, Los Angeles, CA 90095.
David MeriwetherDepartment of Obstetrics and Gynecology, University of California, Los Angeles, CA 90095.
Christina Charles-SchoemanDepartment of Medicine, University of California, Los Angeles, CA 90095.
Srinivasa T ReddyDepartment of Medicine, University of California, Los Angeles, CA 90095; Department of Obstetrics and Gynecology, University of California, Los Angeles, CA 90095; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095 and.
Alan M FogelmanDepartment of Medicine, University of California, Los Angeles, CA 90095.
Mohamad NavabDepartment of Medicine, University of California, Los Angeles, CA 90095.
Otto O YangDepartment of Medicine, University of California, Los Angeles, CA 90095; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
University of California, Los Angeles · US

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 1985 to 2019
$55.2M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITSUYASU, RONALD T. · 1991 to 2018
$39.9M
Prospective Evaluation of Antiviral Therapy and Cardiac HealthR01HL095132 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S., STEIN, JAMES H · 2008 to 2012
$4.0M
Optimizing Antiretroviral Therapy in HIV K24AI056933 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2003 to 2013
$1.4M
HDL Function as a Biomarker for Atherosclerotic Risk in Rheumatoid ArthritisK23HL094834 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHARLES-SCHOEMAN, CHRISTINA · 2009 to 2013
$693k
NHLBI NIH HHS HL-30568NHLBI NIH HHS K23 HL094834NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL-095132NHLBI NIH HHS R01 HL095132NIAID NIH HHS AI-28697NIAID NIH HHS K24 AI056933NIAID NIH HHS P30 AI028697
6 · The paper itself

Abstract

Most current assays of HDL functional properties are cell-based. We have developed a fluorometric biochemical assay based on the oxidation of dihydrorhodamine 123 (DHR) by HDL. This cell-free assay assesses the intrinsic ability of HDL to be oxidized by measuring increasing fluorescence due to DHR oxidation over time. The assay distinguishes the oxidative potential of HDL taken from different persons, and the results are reproducible. Direct comparison of this measurement correlated well with results obtained using a validated cell-based assay (r(2) = 0.62, P < 0.001). The assay can be scaled from a 96-well format to a 384-well format and, therefore, is suitable for high-throughput implementation. This new fluorometric method offers an inexpensive, accurate, and rapid means for determining the oxidative properties of HDL that is applicable to large-scale clinical studies.

Indexed as

AnimalsApolipoprotein A-IArtifactsCell-Free SystemDose-Response Relationship, DrugFemaleFluorescent DyesFluorometryHumansInflammationLipoproteins, HDLMaleMiceOxidation-ReductionReproducibility of ResultsRhodamine 123Apolipoprotein A-Idihydrorhodamine 123Fluorescent DyesLipoproteins, HDLRhodamine 123Rhodamines

Identifiers

PMID21957198
PMCPMC3220300
OpenAlexW2111362720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.